Entrepreneurial Spirit, Rooted in Tradition. Mitsubishi Tanabe Pharma America, Inc. (MTPA) is a U.S. subsidiary of Mitsubishi Tanabe Pharma Corporation (MTPC) in Japan, which touts a storied reputation more than 300 years in the making. Our parent company - one of Japan’s most respected - is a research-driven pharmaceutical company that has tirelessly pursued medical breakthroughs with global reach. MTPC has discovered and produced several first-in-class medicines for serious diseases, including multiple sclerosis (MS), diabetes mellitus (DM), amyotrophic lateral sclerosis (ALS), and is currently developing medicines in  Neurology in Parkinson’s (PD), Spinal Cord Injury (SCI), and in high unmet areas in Immunology and Oncology.

MTPA is rapidly expanding its operations across all functional areas. MTPA’s commitment to patients and their communities continues with a robust late-stage pipeline of investigational treatments for difficult-to-treat diseases and commercializing products with significant unmet medical needs in North American markets.  In the United States, MTPA launched rare disease treatments including RADICAVA® (edaravone) injectables in 2017 and RADICAVA® (edaravone) oral suspension in 2022. The company handles research, clinical development, sales, marketing, medical affairs, supply chain, and business development functions.  MTPA is dedicated to improving the treatment environment for those with debilitating diseases, researching on real-world evidence, and creating hope for all facing illness.

The Business Development & Licensing - Transaction Lead will be responsible for consistently delivering flawless executed licensing deals that are legally and commercially robust. The BD&L Transaction Lead will be seen as the execution anchor within the BD team – keeping transactions on track and avoiding execution risks. They will have strong credibility with external counterparties and internal stakeholders, building trust through precision, persistence and results. Ideally, this individual will be a transaction advisory professional from investment banking execution teams with experience in biopharma licensing/M&A.

• Deal Execution Leadership: Manage the end-to-end execution of licensing transactions, from term sheet through definitive agreements and closing.
• Contract & Term Sheet Oversight: Draft, review, and refine deal documentation in collaboration with external counsel and internal legal teams; ensure terms are legally sound, commercially balanced, and aligned with financial models.
• Financial Structuring: Partner with Deal Leads and Deal Support to optimize licensing economics (milestones, royalties, equity components, profit-sharing structures).
• Stakeholder Management: Coordinate across internal functions (legal, finance, R&D, commercial) to ensure alignment and timely decision-making.
• External Counterparty Engagement: Serve as a primary interface with partner companies, law firms, advisors, and bankers during transaction execution.
• Risk Anticipation & Resolution: Identify potential roadblocks in contract negotiation and execution, proactively developing solutions to maintain deal momentum.
• Closing Discipline: Ensure flawless execution of final agreements, with all conditions precedent tracked, risks mitigated, and post-closing obligations defined.

• BA or BS required; Advanced degree preferred: JD, MBA, or equivalent transactional/financial training.
• 10+ years of experience in transaction advisory, legal (M&A/licensing), or corporate development within biopharma.
• Advanced degree preferred: JD, MBA, or equivalent transactional/financial training.
• Demonstrated track record of leading execution of complex cross-border transactions.
• Corporate development or BD execution specialists from pharma/biotech with proven track record of closing complex transactions.
• Familiarity with Japanese market and corporate governance is advantageous but not required.
• Willingness to travel and manage multiple simultaneous deal processes.
• Deep familiarity with licensing/M&A contract structures, risk allocation, and regulatory considerations.
• Strong financial literacy, comfortable translating contract terms into economic impact.
• Persistent, detail-oriented “finisher” mentality with ability to keep multiple stakeholders aligned under tight timelines.
• Strong negotiation and interpersonal skills; able to maintain credibility with counterparties and senior leadership.
• Practical problem solver, capable of balancing legal precision with commercial pragmatism.

Our Value Proposition:

Enjoy the fast-moving, entrepreneurial spirit more typically found in a small biotech, complemented by the benefits of a global pharmaceutical/chemical conglomerate.  At this time, Mitsubishi Tanabe Pharma America offers our employees unparalleled opportunities for career success coupled with a supportive level of employee benefits.

MTP provides a competitive benefits package inclusive of Medical and Dental health benefits, short-term and long-term disability plans, Company Paid and Supplemental Life insurance and additional voluntary benefits such as Critical Illness Insurance, Accident Insurance, Legal Plan, and ID Theft Protection.  In addition, we provide a generous PTO policy based on tenure, commencing with 24 PTO days, pro-rated based on hire date.

The salary range for this position is $310,000 - $330,000. Factors such as scope and responsibilities of the position, candidate's work experience, education/training, job-related skills, internal peer equity, as well as market and business considerations may influence base pay offered. This salary may be subject to a geographic adjustment (according to a specific city and state and depending on the role), if an authorization is granted to work outside of the location listed in this posting.

This position is eligible to participate in our annual Short-Term Incentive (STI) program.  Specific information about the plan including eligibility rules and target, will be furnished upon hire.

This position is eligible to participate in our Long-Term Incentive (LTI) program.  Specific information about the plan including eligibility rules and target, will be furnished upon hire.